首页> 美国卫生研究院文献>Journal of Experimental Clinical Cancer Research : CR >Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma
【2h】

Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma

机译:长非编码RNA UBE2CP3通过激活肝细胞癌中的ERK1 / 2 /HIF-1α/ VEGFA信号传导增强HCC细胞分泌VEGFA并促进血管生成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAngiogenesis is considered as an important process in the development of malignancies and is associated with cancer progression and metastasis. Hepatocellular carcinoma (HCC) is the most common primary tumor of the liver and is recognized as a typical angiogenic tumor. Thus, it is of great importance to study the underlying mechanism of angiogenesis in HCC. The long non-coding RNA (lncRNA) ubiquitin conjugating enzyme E2C pseudogene 3 (UBE2CP3) has been reported as an oncogene that promotes tumor metastasis in HCC. However, the role and underlying mechanisms of UBE2CP3 in HCC angiogenesis are still unclear.
机译:背景血管生成被认为是恶性肿瘤发展的重要过程,并且与癌症的进展和转移有关。肝细胞癌(HCC)是最常见的肝原发性肿瘤,被认为是典型的血管生成性肿瘤。因此,研究肝癌血管生成的潜在机制具有重要意义。长期的非编码RNA(lncRNA)泛素结合酶E2C假基因3(UBE2CP3)已被报道为癌基因,可促进HCC中的肿瘤转移。然而,UBE2CP3在肝癌血管生成中的作用和潜在机制仍不清楚。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号